Individual.com logo
Welcome   (I'm not )
Select a date:

My Topics
Click here to add topics
Table bottom

My Companies
Click here to add companies
Table bottom

Newsdesks
Business
Finance
Internet
Computing
Environmental
Energy
Healthcare
Industry News, A-Z
Sports
Telecom
Transportation
Table bottom

Search
Google News
Table bottom

My Settings
Topics
Companies
Personal Info
Preferences
Forgot Password?
Log out
Table bottom

Top Topics
No top stories
Table bottom

Top Topics
Financial Services & Investing
Stock Market
Alternative Energy
Aerospace & Defense
Telecom News
Government
Managed Health Care
Natural Disaster
Economic Indicators
Internet Media, Content & Design
Table bottom

Infectious Disease
Houston Methodist infectious disease scientists have discovered a previously unknown trigger that turns a relatively run-of-the-mill infection into a devastatingly ravenous, flesh-eating disease.</p> Group A streptococcus is an organism that...
Contify, 9:58am ET



Extensive R&amp;D in medical &amp; healthcare sector across North America present promising growth aspects for regional respiratory protective equipment market. Also, severe legislations regarding safety measures by World Health Organization...
Heraldkeeper, 9:13am ET

NEW ORLEANS, Feb. 19 -- Alcon issued the following news release: - Innovative treatment system for Meibomian Gland Dysfunction (MGD) headlines robust Alcon meeting program - New data presentations reinforce the impact of Alcon's...
Contify, 9:08am ET

Lexington, Massachusetts, Feb. 19 -- Pulmatrix issued the following news release: Pulmatrix, Inc. (NASDAQ: PULM) today announces 2018 financial results, reviews the Company's recent progress, and provides an outlook for its pulmonary...
Contify, 9:08am ET

NASHVILLE, Tennessee, Feb. 19 -- Cumberland Pharmaceuticals Inc. issued the following news release: Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release fourth quarter and annual 2018 financial results after...
Contify, 9:03am ET

IFFY, a blockchain-based application, today announced the launch of their decentralized healthcare record-keeping platform. Users can privately and securely store their medical records on the platform, and grant access to STD test results via...
ABNewswire, 8:53am ET

HOPKINTON, Massachusetts, Feb. 19 -- Spring Bank Pharmaceuticals issued the following news release: Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the...
Contify, 8:48am ET

RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company primarily focused on proprietary drugs for gastrointestinal (GI) diseases, today announced that it has...
GlobeNewswire, 8:39am ET

“Global Amyloidosis Treatment Market (By Types, By Applications, By Leading Regions and Crucial Players) by Crystal Market Research– Segments Outlook, Business Assessment, Competition Scenario, Trends and Forecast 2019-2025” investigations...
Heraldkeeper, 8:33am ET

Inovio Pharmaceuticals, Inc. (NASDAQ: INO) in collaboration with The Wistar Institute and the University of Pennsylvania announced today that the first subject was dosed as part of the first-ever human study of Inovio's DNA-encoded monoclonal...
PR Newswire, 8:08am ET

Abbott (NYSE: ABT) announced today it has received CE Mark for the world's most sensitive rapid diagnostic test for the detection of hepatitis B surface antigen, the Determine(TM) HBsAg 2 test for use with serum, plasma or whole blood.1,2,3 This...
PR Newswire, 8:08am ET

-- The approval marks HUMIRA as the only approved biologic treatment option in Canada for pediatric patients from two years of age with chronic non-infectious anterior uveitis who have had inadequate response to conventional.
CNW Group, 8:08am ET

Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that Will Lewis, Chairman and Chief Executive Officer of Insmed, will present at...
PR Newswire, 8:08am ET

- New point-of-care rapid test identifies and helps make effective care more accessible for millions of people living with hepatitis B, in support of World Health Organization (WHO) hepatitis targets - Life-changing test has obtained...
PR Newswire Europe, 8:08am ET

The US Food and Drug Administration (FDA) has accepted a new drug application (NDA) submitted by AbbVie for its investigational medicine upadacitinib to treat adults with moderate to severe rheumatoid arthritis. The regulatory agency has...
MarketLine, 7:58am ET

Mallinckrodt Pharmaceuticals (NYSE:MNK), a leading global specialty pharmaceutical company, today announced interim analysis results of its company-sponsored, Phase 3, single-arm, open-label, multi-center study assessing the efficacy of treating...
PR Newswire, 7:43am ET

Generic oncology drugs, being able to detect and treat tumors, are utilized extensively in the healthcare industry for treating cancer. Notable enhancements in the technology with the blend of information is expected to accelerate the pace of...
PR Newswire Europe, 7:43am ET

Generic oncology drugs, being able to detect and treat tumors, are utilized extensively in the healthcare industry for treating cancer. Notable enhancements in the technology with the blend of information is expected to accelerate the pace of...
PR Newswire, 7:43am ET

There's no question that sex education has always been awkward. Most of us remember when we learned about the reproductive system, "the birds and the bees." As uncomfortable as that may be, early on we are taught the importance of...
University Wire, 7:28am ET

The Microsurgery robot Market to exceed USD 1.7 billion by 2024; according to a new research report by Global Market Insights. Increasing demand for minimally invasive surgical procedure will remarkably drive microsurgery robot market growth over...
Heraldkeeper, 7:23am ET

1-20 of 296
Next 20 >>


Tell a Friend About Us

Home Help My Settings Privacy Policy Terms of Service Advertising About Us Contact Us Logout

Copyright 1995-, Individual.com. No redistribution allowed.